CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Drug survival of tumor necrosis factor α inhibitors in patients with ankylosing spondylitis in Korea
Hyemin Jeong, Yeong Hee Eun, In Young Kim, Hyungjin Kim, Joong Kyong Ahn, Jaejoon Lee, Eun-Mi Koh, Hoon-Suk Cha
Korean J Intern Med. 2018;33(2):407-416.   Published online 2016 October 12    DOI: https://doi.org/10.3904/kjim.2016.042

Excel Download

Drug survival of tumor necrosis factor α inhibitors in patients with ankylosing spondylitis in Korea
The Korean Journal of Internal Medicine. 2018;33(2):407-416   Crossref logo
Link1 Link2 Link3

The Incidence of Uveitis in Ankylosing Spondylitis Patients Undergoing Tumor Necrosis Factor Inhibiting Therapy in Korea
Journal of Rheumatic Diseases. 2015;22(6):335   Crossref logo
Link1

Drug Survival Rates of Tumor Necrosis Factor Inhibitors in Patients with Rheumatoid Arthritis and Ankylosing Spondylitis
Journal of Korean Medical Science. 2014;29(9):1205   Crossref logo
Link1

Tumour necrosis factor inhibitors in ankylosing spondylitis
Internal Medicine Journal. 2008;38(10):781-789   Crossref logo
Link1

Cost–benefit analysis of tumor necrosis factor inhibitors in ankylosing spondylitis
Nature Clinical Practice Rheumatology. 2006;2(5):237-238   Crossref logo
Link1 Link2 Link3

PMS1 Tumor Necrosis Factor Alpha Inhibitors for the Treatment of Active Ankylosing Spondylitis
Value in Health. 2011;14(7):A302   Crossref logo
Link1 Link2

PAR4 ECONOMIC EVALUATION OF TUMOR NECROSIS FACTOR INHIBITORS IN THE TREATMENT OF ANKYLOSING SPONDYLITIS
Value in Health. 2007;10(3):A118   Crossref logo
Link1 Link2

PAR13 TUMOR NECROSIS FACTOR INHIBITORS— A PHARMACOECONOMIC REVIEW OF ITS USE IN ANKYLOSING SPONDYLITIS
Value in Health. 2007;10(3):A120-A121   Crossref logo
Link1 Link2

Different response to rituximab in tumor necrosis factor blocker-naive patients with active ankylosing spondylitis and in patients in whom tumor necrosis factor blockers have failed: A twenty-four-week clinical trial
Arthritis & Rheumatism. 2010;62(5):1290-1297   Crossref logo
Link1

Tuberculosis in patients with ankylosing spondylitis treated with anti tumor necrosis factor
International Journal of Infectious Diseases. 2014;21:355   Crossref logo
Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Korean J Intern Med has participated in CrossRef Text and Data Mining service since August 31, 2015.